UCB

#MitoAwarenessWeek highlights mitochondrial diseases like #TK2d. Delays in diagnosis due to limited knowledge & similarities with other myopathies can impact outcomes for the TK2d community. UCB is committed to increasing education for accurate diagnoses. More about TK2d: www.ucb.com/solutions/di...

It's #TK2dTuesday! #TK2d affects 1.64 per 1 million globally, with varied onset and severity. UCB is committed to elevating understanding of the disease through collaboration with the community.

FOR MEDIA: UCB presents latest research advancements across leading neurology portfolio at the International Epilepsy Congress, read more www.ucb.com/newsroom/pre...

#IEC2025 #epilepsy

🌍 Named one of @time.com and Statista’s World’s Most Sustainable Companies of 2025 | #129 globally, #2 in Belgium

🅰️ Awarded an “A” Score by CDP for Supplier Engagement, recognizing our commitment to responsible sourcing and transparent collaboration across our value chain. This complements our A- CDP scores for climate change and water security.

🏆 Ranked #1 in the Biotech sector by Sustainalytics for the second year in a row

The image reads: We’re growing responsibly. We’re advancing our environmental and social commitments, strengthening transparency across our value chain.

Growth is one thing. Doing it responsibly is another. We’re doing both. 🌱 🔗 Learn more: www.ucb.com/investors/pe...

#TeamUCB #Sustainability

📈 #UCBusinessUpdate
At the half-year mark, we’re proud of #TeamUCB’s progress, as we’re driving sustainable growth and delivering for people living with severe diseases. For more, visit ucb.com: www.ucb.com/investors/ma...
#InspiredByPatients #DrivenByScience

FOR MEDIA: UCB presents the latest research advancements at the European Pediatric Neurology Society Congress, read more www.ucb.com/newsroom/pre...

#EPNS

Sustainability | UCB Sustainability | UCB

To learn more about our sustainability efforts, visit:
🔗 www.ucb.com/about-ucb/su...
For the full list of companies:
🔗 time.com/collection/w...

Proud to be named one of TIME & Statista’s World’s Most Sustainable Companies 2025! #129 globally, #2 in BE. Another milestone in our journey to responsible, ethical innovation. #Sustainability

UCB is dedicated to raising awareness of #MyastheniaGravis and its impact.

Anna Kole emphasizes that elevating the community’s voice via initiatives like #FacesofMG can help identify how to support those living with MG and help improve standards of care. #MGAwarenessMonth

Unveiling new insights at this year’s European Academy of Neurology (#EAN) Congress. We're focused on improving life for those with #MyastheniaGravis & #Epilepsy. Together, let's make a difference!
Learn more: www.ucb.com/solutions/di...

Developmental and epileptic encephalopathies (DEEs) don’t just affect children. At 17, Mia is living with Dravet syndrome (DS), facing the difficult transition to adult care.
Learn more about DS here:
www.ucb.com/solutions/di...
#DravetAwareness #MoreThanSeizures

On #DravetAwarenessDay, we remember Dr Charlotte Dravet, the pediatric epilepsy specialist who first described Dravet syndrome and was a leading advocate for improved care for children with epilepsy.

Thank you, Charlotte

On #DravetAwarenessDay UCB’s Andrea Wilkinson explains why Dravet syndrome and other developmental and epileptic encephalopathies are about #MoreThanSeizures and impact all aspects of daily life for patients and their families. Find out more here www.ucb.com/innovation/m...

CDD is about #MoreThanSeizures, it’s about daily challenges and interruptions to family life, it’s about skipping lunch to provide care.

On World #CDKL5 Day, hear from Karen Utley, President & Co-Founder, International Foundation for CDKL5 Research, about her experiences.

#CDKL5awareness

#MyastheniaGravis (MG) deeply affects daily life, with fluctuating, often invisible symptoms that make diagnosis uniquely challenging.
At UCB, we’re committed to working with the #MG community to address care gaps. #MGAwarenessMonth.

Learn more about myasthenia gravis here: bit.ly/4j5NIT1

To mark #MGAwarenessMonth, we're highlighting the importance of understanding #MyastheniaGravis (MG), a widely misunderstood rare condition.

UCB aims to create solutions to tackle the challenges faced by those living with #MG.

Discover more about MG here: bit.ly/4j5NIT1

At this year’s Myasthenia Gravis Foundation of America's (#MGFA) International Conference, we look forward to sharing our latest data in #MG. We aim to contribute valuable insights that can lead to better understanding and management of MG.

Learn more here: bit.ly/4j5NIT1

FOR MEDIA: UCB presents expansive data set at 15th Myasthenia Gravis Foundation of America (MGFA) International Conference, read more www.ucb.com/newsroom/pre...

#MGFA #MyastheniaGravis #MG

We’re thrilled to attend the year’s Myasthenia Gravis Foundation of America's (#MGFA) International Conference, where we’ll share 21 presentations across our targeted portfolio in #MG. Will you be part of the conversation?

Learn more here: bit.ly/4j5NIT1